Creutzfeldt-Jakob Disease Following Corneal Transplantation

Cornea

Volumn 23, Issue 4, 2004, Pages 406-408

  Hammersmith, Kristin M ^a   Cohen, Elisabeth J ^a,b   Rapuano, Christopher J ^a   Laibson, Peter R ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

^b WILLS EYE HOSPITAL   (United States)

Author keywords

Cornea transplant; Creutzfeldt Jakob disease

Indexed keywords

AGED; CASE REPORT; CORNEA DYSTROPHY; CORNEA SURGERY; CORNEA TRANSPLANTATION; CREUTZFELDT JAKOB DISEASE; FEMALE; GERIATRIC PATIENT; HUMAN; IATROGENIC DISEASE; PENETRATING KERATOPLASTY; PRIORITY JOURNAL; REVIEW; TREATMENT OUTCOME; VISUAL ACUITY;

AGED; AGED, 80 AND OVER; CREUTZFELDT-JAKOB SYNDROME; DISEASE TRANSMISSION, HORIZONTAL; FATAL OUTCOME; FEMALE; HUMANS; IATROGENIC DISEASE; KERATOPLASTY, PENETRATING; RISK FACTORS; TISSUE DONORS;

EID: 2142825742     PISSN: 02773740     EISSN: None     Source Type: Journal    
DOI: 10.1097/00003226-200405000-00019     Document Type: Review

References (20)

1. National Prion Disease Pathology Surveillance Center, Case Western Reserve, Cleveland, Ohio. Available at http://www.cjdsurveillance.com
2. Prusiner SB. Novel proteinaceous infectious particles cause scrapie. Science. 1982;216:136-144.
3. Lueck C, McIlwaint G, Zeidler M. Creutzfeldt-Jakob disease and the eye. Background and patient management. Eye. 2000;14:263-290.
4. Bernoulli D, Siegfried J, Baumgartner G, et al. Danger of accidental person-to-person transmission of Creutzfeldt-Jakob disease by surgery. Lancet. 1977;1:478-479.
5. Prichard J, Thadani V, Kalb R, et al. Rapidly progressive dementia in a patient who received a cadaveric dura mater graft. MMWR. 1987;36:49-55.
6. Hintz R, MacGillivray M, Joy A, et al. Fatal degenerative neurological disease in patients who received pituitary-derived human growth hormone. N Engl J Med. 1985;313:734-738.
7. Duffy P, Wolf J, Collins G, et al. Possible person-to-person transmission of Creutzfeldt-Jakob disease. N Engl J Med. 1974;290:692-693.
8. Uchiyama K, Ishida C, Yago S, et al. An autopsy case of Creutzfeldt-Jakob disease associated with corneal transplantation. Dementia. 1994;8:466-473.
9. Heckmann JG, Lang CJC, Petruch F, et al. Transmission of Creutzfeldt-Jacob disease via a corneal transplant. J Neurol Neurosurg Psychiatry. 1997;63:388-390.
10. Rabinstein AA, Whiteman ML, Sherbert RT. Abnormal diffusion-weighted magnetic resonance imaging in Creutzfeldt-Jakob disease following corneal transplantations. Arch Neurol. 2002;59:637-639.
11. Will RG, Ironside JW, Zeidler M, et al. A new vaiant of Creutzfeldt-Jakob disease in the UK. Lancet. 1996;347:921-925.
12. Brown P, Gibbs CL, Rodgers-Johnson P, et al. Human spongiform encephalopathy: the National Institutes of Health series of 300 cases of experimental transmitted disease. Ann Neurol. 1994;35:513-529.
13. Lee KH, Harrington M. Pre-mortem diagnosis of Creutzfeldt-Jakob disease by cerebrospinal fluid analysis. Lancet. 1996;348:887.
14. World Health Organization. Global Surveillance, Diagnosis and Therapy of Human Transmissible Encephalopathies: Report of a WHO Consultation. WHO/EMC/ZDI/98.9. Geneva: World Health Organization, 1998.
15. Kennedy RH, Hogan RN, Brown P, et al. Eye banking and screening for Creutzfeldt-Jakob disease. Arch Ophthalmol. 2001;119:721-726.
16. Eye Bank Association of America. Medical Standards 2001, M1.000.
17. Eye Bank Association of America. Medical Standards 2003, M1.100.
18. Hogan RN, Brown P, Heck E, et al. Risk of prion disease transmission from ocular donor tissue transplantation. Cornea. 1999;18:2-11.
19. American Red Cross. Available at http://www.redcross.org. Last accessed May 22, 2003.
20. Prusiner SB. Human Prion Diseases. In: Principles and Practices of Clinical Virology, 4th ed. New York: John Wiley & Sons, 2000:711-747.